Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
3751
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.42M | ﹤0.01% |
138,900
-65,400
| -32% | -$1.72M |
|
|
HBI
3752
PUT
DELISTED
Hanesbrands
HBI
| $4.42M | ﹤0.01% |
302,900
+1,800
| +0.6% | +$27.2K |
|
3753
PUT
iShares Russell 1000 Value ETF
IWD
$84.2B
| $4.42M | ﹤0.01% |
32,300
-16,800
| -34% | -$2.15M |
|
|
DFS
3754
DELISTED
Discover Financial Services
DFS
| $4.41M | ﹤0.01% |
48,760
-72,497
| -60% | -$5.41M |
|
3755
CALL
British American Tobacco
BTI
$123B
| $4.41M | ﹤0.01% |
117,700
+15,900
| +16% | +$569K |
|
3756
Tyson Foods
TSN
$20.5B
| $4.41M | ﹤0.01% |
68,441
-788,426
| -92% | -$49M |
|
3757
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $4.41M | ﹤0.01% |
46,000
-13,200
| -22% | -$1.27M |
|
3758
1-800-Flowers.com
FLWS
$262M
| $4.41M | ﹤0.01% |
169,530
+94,126
| +125% | +$2.29M |
|
|
ACB
3759
PUT
Aurora Cannabis
ACB
$233M
| $4.41M | ﹤0.01% |
53,010
+29,470
| +125% | +$2.15M |
|
3760
CALL
Adaptive Biotechnologies
ADPT
$3.94B
| $4.41M | ﹤0.01% |
74,500
+20,300
| +37% | +$1.05M |
|
|
FSDC
3761
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $4.4M | ﹤0.01% |
400,000
| – | – |
|
3762
PUT
National Beverage
FIZZ
$2.93B
| $4.4M | ﹤0.01% |
103,600
+6,400
| +7% | +$275K |
|
3763
CALL
BorgWarner
BWA
$14B
| $4.39M | ﹤0.01% |
129,129
-89,778
| -41% | -$3.04M |
|
|
LTHM
3764
CALL
DELISTED
Livent Corporation
LTHM
| $4.39M | ﹤0.01% |
233,000
+117,700
| +102% | +$1.64M |
|
3765
Advanced Drainage Systems
WMS
$11.4B
| $4.39M | ﹤0.01% |
52,503
+4,187
| +9% | +$297K |
|
3766
iShares Asia 50 ETF
AIA
$5.06B
| $4.39M | ﹤0.01% |
+50,317
| New | +$4.02M |
|
3767
Fiverr
FVRR
$324M
| $4.39M | ﹤0.01% |
22,479
-13,939
| -38% | -$2.52M |
|
3768
Invesco Water Resources ETF
PHO
$2.05B
| $4.38M | ﹤0.01% |
94,398
-34,675
| -27% | -$1.52M |
|
|
PVG
3769
PUT
DELISTED
PRETIUM RESOURCES INC.
PVG
| $4.38M | ﹤0.01% |
381,700
+203,800
| +115% | +$2.45M |
|
|
GNCA
3770
DELISTED
Genocea Biosciences, Inc.
GNCA
| $4.38M | ﹤0.01% |
1,808,732
+10,729
| +0.6% | +$24.4K |
|
3771
Schneider National
SNDR
$6.33B
| $4.38M | ﹤0.01% |
+211,421
| New | +$4.73M |
|
|
MASI
3772
PUT
DELISTED
Masimo
MASI
| $4.38M | ﹤0.01% |
16,300
-8,800
| -35% | -$2.19M |
|
3773
Amplify Online Retail ETF
IBUY
$125M
| $4.37M | ﹤0.01% |
38,258
+8,390
| +28% | +$853K |
|
3774
CALL
Essex Property Trust
ESS
$18.5B
| $4.37M | ﹤0.01% |
18,400
+6,300
| +52% | +$1.45M |
|
3775
CALL
Service Corp International
SCI
$11.5B
| $4.37M | ﹤0.01% |
88,900
+74,400
| +513% | +$3.53M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.